首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New derivatives of 4 '-phenyl-2,2 ':6 ',2 ''-terpyridine as promising anticancer agents
【24h】

New derivatives of 4 '-phenyl-2,2 ':6 ',2 ''-terpyridine as promising anticancer agents

机译:4'-phenyl-2,2':6',2'' - 吡啶作为有前途的抗癌剂的新衍生物

获取原文
获取原文并翻译 | 示例
           

摘要

Terpyridine derivatives are known from their broad application including anticancer properties. In this work we present the newly synthesized 4'-phenyl-2,2':6',2 ''-terpyridine group with high anti-proliferative activity. We suggest that these compounds influence cellular redox homeostasis. Cancer cells are particularly susceptible to any changes in the redox balance because of their handicapped and inefficient antioxidant cellular systems. The antiproliferative activity of the studied compounds was tested on five different cell lines that represent several types of tumours; glioblastoma, leukemia, breast, pancreatic and colon. Additionally, we also tested their selectivity towards normal cells. We performed molecular biology studies in order to detect the response of a cell to its treatment with the compounds that were tested. We looked at the in-depth changes in the proteins and cellular pathways that lead to cell cycle inhibition (G0/G1 and S), and consequently, death on the apoptosis and autophagy pathways. We proved that the studied compounds targeted DNA as well. Special attention was paid to the targets connected with ROS generation. (C) 2020 Elsevier Masson SAS. All rights reserved.
机译:三联吡啶衍生物的广泛应用包括抗癌特性。在这项工作中,我们介绍了新合成的具有高抗增殖活性的4'-苯基-2,2':6',2'-三吡啶基团。我们认为这些化合物影响细胞氧化还原稳态。癌细胞尤其容易受到氧化还原平衡的任何变化的影响,因为它们的抗氧化细胞系统是残缺和低效的。在代表几种肿瘤的五种不同细胞系上测试了所研究化合物的抗增殖活性;胶质母细胞瘤、白血病、乳腺、胰腺和结肠。此外,我们还测试了它们对正常细胞的选择性。我们进行了分子生物学研究,以检测细胞对受试化合物处理的反应。我们观察了导致细胞周期抑制(G0/G1和S)的蛋白质和细胞途径的深度变化,以及凋亡和自噬途径的死亡。我们证明所研究的化合物也以DNA为靶点。特别关注与活性氧生成相关的目标。(C) 2020年爱思唯尔马森SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号